Afatinib Dimaleate Intermediate CAS 314771-76-1 Ubunyulu > 99.0% (HPLC) Factory
I-Ruifu Chemical Supply Intermediates ye-Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino)i-acetaldehyde I-Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
I-Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4 (1H)-enye CAS 162012-69-3
I-7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-DiamineI-CAS 314771-76-1
(S)-N-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl)oxy)quinazolin-4-AmineI-CAS 314771-88-5
Igama leMchiza | (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine |
Izithethantonye | N4-(3-Chloro-4-Fluorophenyl) -7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Ukungacoceki kwe-Afatinib B;I-Afatinib-des(4-Dimethylamino-2-en-1-oxo)butyl;Des(4-Dimethylamino-2-en-1-oxo)butyl Afatinib |
Inombolo yeCAS | 314771-76-1 |
Inombolo yeCAT | RF-PI2028 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ye-100MT/Unyaka |
Ifomula yeemolekyuli | I-C18H16ClFN4O2 |
Ubunzima beMolekyuli | 374.8 |
Indawo yokubilisa | 559.0±50.0℃ |
Ukuxinana | 1.473±0.060 g/cm3 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMthubi oKhanyayo ukuya kumthubi |
Ukuchongwa | Ixesha lokuGcinwa kweNqununu kwi-HPLC kufuneka lihambelane noMgangatho |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | <0.20% |
Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Iintsimbi ezinzima (njenge Pb) | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Phakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
(S)-N4- (3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) iphakathi kwe-Afatinib Dimaleate (CAS: 850140-73-7).I-Afatinib isizukulwana sesibini esinamandla kunye nesingenakuguquleka se-inhibitor ye-epidermal growth factor receptor (EGFR) kunye ne-epidermal growth factor receptor 2 (HER2) i-tyrosine kinase, ephuhliswe nguBoehringer Ingelheim, eJamani.Iyakwazi ukuvimbela ngokungenakuguqulwa umsebenzi we-tyrosine kinase ngokufumana impendulo kaMichael kunye neqela le-thiol le-cysteine kwindawo ye-797 ye-EGFR.Umsebenzi: 1. NjengeLapatinib kunye neNeratinib, i-Afatinib yi-protein kinase inhibitor ephinda ivimbele ngokungenakuphikiswa i-epidermal growth factor receptor 2 (Her2) kunye ne-epidermal growth factor receptor (EGFR) kinases.2. I-Afatinib ayisebenzi kuphela ngokumalunga nokuguqulwa kwe-EGFR ekujoliswe kuyo yi-TKI yesizukulwana sokuqala njenge-erlotinib okanye i-gefitinib, kodwa kunye nokuguqulwa kwenguqu efana ne-T790M engabalulekanga kula mayeza aqhelekileyo.Ngenxa yomsebenzi wayo owongezelelweyo ngokuchasene ne-Her2, iphandwa umhlaza wamabele kunye neminye imihlaza eqhutywa yi-EGFR kunye ne-Her2.3. I-Afatinib iyeza lonyango lokuqala lwezigulane ezineentlobo ezahlukeneyo ze-metastatic (EGFR mutation positive) engeyiyo encinci ye-cell lung carcinoma (NSCLC).Isebenza njenge-inhibitor ye-covalent engenakuguqulwa ye-receptor tyrosine kinases ye-epidermal growth factor receptor (EGFR) kunye ne-erbB-2 (HER2).